FDA Panel Recommends Against Following White House Plan for Booster Doses for All
A U.S. Food and Drug Administration (FDA) committee voted unanimously Friday to recommend booster doses of Pfizer-BioNTech’s COVID-19 vaccine for those over age 65 and those at…